NextCell Pharma AB

Catch up with our CEO Mathias Svahn at Advanced Therapies in #Philadelphia this week! Mathias will join the #panel discussion on Leveraging real-world evidence to facilitate patient access tomorrow as well as present NextCell Pharma AB 's latest data on the use of our #msc #drugproduct ProTrans for the treatment of #type1diabetes. #celltherapy #cgt #cellandgenetherapy #atmps #t1d #mesenchymalstromalcells #mesenchymalstemcells #patientaccess #patientfirst #development #networking #collaboration #conference https://lnkd.in/dDSxfaSw

An exciting first day at #BioEurope, with a strong spotlight on #ATMP development in Sweden! Flemingsberg-based NextCell Pharma AB and one of our inspiring ATMP heroes, CEO Mathias Svahn, had the chance to connect with Ebba Busch at the vibrant Swedish pavilion. We proudly showcased our ATMP Flemingsberg platform and officially launched our #ATMPheroes campaign. Stay tuned! #joinswedishlifesciences #innovationsforlife #atmpflemingsberg Learn more about our campaign and meet the heroes 👉 https://lnkd.in/dfYphsGs Direct link to campaign 👉 https://lnkd.in/drFUdzuG Laura Baqué Vidal, PhD Aditya Harisankar Arnika Wagner Lindsay Davies Martin Sundin Aud Sølvberg Sofie Falk Jansson Lilian Walther Jallow Mathias Svahn

Absolutely fantastic response to the release of our QC posts for QVance! Will slowly work my way through the many applications so please bare with me! #cgt #qc #cellandgenetherapy #atmps #celltherapy #quality #qualitycontrol NextCell Pharma AB #startup #analytics

Great job QVance! Great to see our new daughter company receiving so much positive attention and QC engineers wanting to join the team! 👏 #qc #atmps #cgt #atmps #celltherapy #cellandgenetherapy #startup #growingteam #quality #qualitycontrol #analytics

This week NextCell Pharma AB welcomes Hooi Ching Lim as our new Head of Development! Hooi Ching has a wealth of experience with #mesenchymalstromalcells and #productdevelopment for clinical use. Hooi Ching will work with our #production and #research teams to push forward our #pipeline with #ProTrans. Welcome Hooi Ching! #cgt #cellandgenetherapy #celltherapy #t1d #type1diabetes #growth #newstaff #expansion #development #mscs #atmps

A big day for our daughter company QVance which went live today! QVance was born out of a recognition through NextCell Pharma AB own clinical development that there is a need for #QC support for companies working in the #atmp space that have specific requirements and #challenges. We are proud to recognise QVance as part of the Group and support them on their vision to become a one-stop analytics provider for #advancedtherapy developers. QVance will officially launch at ATMP Sweden in November but already is recruiting with posts for a Senior #QC engineer and QC engineer launched today. See link below to apply and join our new #startup! https://lnkd.in/dtUAadsH #cgt #cellandgenetherapy #celltherapy #atmps #QC #analytics #solutions #development #gmp #expansion #growth #success

NextCell Pharma AB's team is expanding! We welcome Marco Rossini to the team! Marco will join our #RUO #production team in #Stockholm. #celltherapy #cellandgenetherapy #atmps #huddinge #flemingsberg #type1diabetes #mscs #mesenchymalstromalcells #t1d #development #manufacturing

NextCell Pharma AB's CEO Mathias Svahn is in Japan this week! Mathias has been invited by Business Sweden to present the company and its ongoing clinical development at the Swedish Embassy in #Tokyo. NextCell will also attend BioJapan / JTB Communication Design as it builds towards it #global #strategy for development and #commercialisation of its drug product ProTrans Read more in the below press release from this morning! #cgt #celltherapy #atmps #cellandgenetherapy #t1d #type1diabetes #msc #mesenchymalstromalcells #development #asia https://lnkd.in/dN_5rpnk

Back to back good news! Dagens Medicin Sverige have featured #type1diabetes treatments and the future of new #innovation in this area this week. Great to see so much development and consideration going into therapies to slow and reverse #disease progression! NextCell Pharma AB's #mesenchymalstromalcell drug product, #ProTrans received some attention with Per-Ola Carlsson, Principal investigator of Uppsala University's Phase II interventional study with ProTrans in newly-diagnosed paediatric #t1d patients highlighted. Great to be at the forefront of innovation in this area and contributing to the field of #newtherapies for #unmetclinical need! Read more in our press release and Dagens Medicin Sverige #cgt #celltherapy #cellandgenetherapy #atmps #sweden #diabetes #drugdevelopment #clinicaltrials https://lnkd.in/dkMeZqkW

This week NextCell Pharma AB announced the treatment of the first four children in the younger cohort (7-12 years) of the Phase II ProTrans-YOUNG paediatric trial run out of Uppsala University. The trial, treating newly diagnosed #type1diabetes children with our #mesenchymalstromalcell drug product has generated alot of interest with recruitment covering the whole of #Sweden! Read more about the study and its progress in our #pressrelease #cgt #celltherapy #t1d #cellandgenetherapy #atmps #msc https://lnkd.in/dq-86Vef